430535-29-8Relevant academic research and scientific papers
MACROCYCLIC KINASE INHIBITORS
-
Page/Page column 90, (2012/06/16)
Compounds of Formula (I): wherein variables are defined herein, and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers for which FAK inhibition is beneficial.
ISOXAZOLE DERIVATIVES
-
, (2008/06/13)
A compound represented by the formula (I) wherein one of R1 and R2 is a hydrogen atom or a substituent and the other is an optionally substituted cyclic group; W is a bond or a divalent aliphatic hydrocarbon group; Y is a group of th
